• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.53% Nasdaq Up 0.11%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    9.89 Up 0.21(2.17%) 4:00PM EDT
    |After Hours : 9.89 Down 0.01 (0.10%) 4:00PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:9.68
    Open:9.67
    Bid:9.89 x 1100
    Ask:9.90 x 4400
    1y Target Est:21.60
    Beta:6.65
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:9.51 - 9.93
    52wk Range:8.84 - 18.48
    Volume:1,223,775
    Avg Vol (3m):1,678,850
    Market Cap:1.02B
    P/E (ttm):N/A
    EPS (ttm):-1.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXUp 2.17%1.02B
    BAXDown 2.44%20.17B
    SHPGDown 0.93%47.62B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):501.40
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.90
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback